Skip to content
Friday, October 16, 2026
Stay updated with the newest tech trends, gadget reviews, a…

TikTok Influencers Fueling Unofficial Trade for Unlicensed Weight-Loss Medication

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

However, physicians and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Elimination

Based on TikTok, the platform has removed problematic content and prohibited associated keywords and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also found groups with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, positive testimonials and step-by-step instructions for preparing or administering at home.

After moments of entering one group, a seller shared WhatsApp details, where the majority of purchases take place. The vendor provided an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Details and Costs

Within these communities, messages show dark colored parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject users to potentially significant health risks”.

SW
About the author

Steven Ward

A tech journalist with over a decade of experience covering AI, cybersecurity, and consumer electronics trends.

UpdateHub

Type to search articles.